Tanaka H et al. |
Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha. |
1999 |
Allergy |
pmid:10380781
|
Elissalde MH and Beier RC |
Stimulation and release of prostaglandins and thromboxane from macrophages by cotton dust associated lipopolysaccharides. |
1990 |
Am Ind Hyg Assoc J |
pmid:2270833
|
Andersson T et al. |
Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers. |
2012 |
Am J Cardiovasc Drugs |
pmid:22631032
|
Leese PT et al. |
Valdecoxib does not impair platelet function. |
2002 |
Am J Emerg Med |
pmid:12098171
|
Jung TT and Juhn SK |
Prostaglandins in human cholesteatoma and granulation tissue. |
1988 |
Am J Otol |
pmid:3177602
|
Mehta P et al. |
Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors. |
1985 |
Am J Pediatr Hematol Oncol |
pmid:2994511
|
Natarajan G et al. |
Chorioamnionitis and ontogeny of circulating prostaglandin and thromboxane in preterm infants. |
2008 |
Am J Perinatol |
pmid:18726836
|
Brown HL et al. |
Plasma and amniotic fluid prostacyclin and thromboxane in mild pregnancy-induced hypertension. |
1987 |
Am J Perinatol |
pmid:3566883
|
Satterfield S et al. |
Biochemical markers of compliance in the Physicians' Health Study. |
1990 Sep-Oct |
Am J Prev Med |
pmid:2268456
|
Ingster LM and Feinleib M |
Salicylate intake and cardiovascular disease: Ingster and Feinleib respond to Hu and Willett. |
1998 |
Am J Public Health |
pmid:9702172
|
Cambria RA et al. |
Thromboxane synthetase inhibition decreases polymorphonuclear leukocyte activation following hindlimb ischemia. |
1991 |
Am Surg |
pmid:1847027
|
Montalescot G et al. |
Early thromboxane release during pacing-induced myocardial ischemia with angiographically normal coronary arteries. |
1990 |
Am. Heart J. |
pmid:2248190
|
Hirsh PD et al. |
Influence of blood sampling site and technique on thromboxane concentrations in patients with ischemic heart disease. |
1982 |
Am. Heart J. |
pmid:7102506
|
Smith EF and Lefer AM |
Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen. |
1981 |
Am. Heart J. |
pmid:7211667
|
Nakashima Y et al. |
Sustained-release nifedipine (nifedipine-L) suppresses plasma thromboxane B2 and 6-keto prostaglandin F1 alpha in both young male smokers and nonsmokers. |
1990 |
Am. Heart J. |
pmid:2353613
|
Ikonomidis I et al. |
Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. |
2005 |
Am. Heart J. |
pmid:15894964
|
Kishi Y et al. |
Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris. |
1992 |
Am. Heart J. |
pmid:1736562
|
Tomoda H |
Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046). |
1986 |
Am. Heart J. |
pmid:3532743
|
Nitz RE and Martorana PA |
The activity of molsidomine in experimental models of ischemic cardiac disease. |
1985 |
Am. Heart J. |
pmid:3919549
|
Buchanan MR et al. |
Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease. |
1987 |
Am. Heart J. |
pmid:2953219
|
Walinsky P et al. |
Thromboxane A2 in acute myocardial infarction. |
1984 |
Am. Heart J. |
pmid:6485997
|
Rubenstein MD et al. |
Platelet activation in clinical coronary artery disease and spasm. |
1981 |
Am. Heart J. |
pmid:6455912
|
De Caterina R et al. |
Inhibition of platelet function during in vivo infusion of isosorbide mononitrates: relationship between plasma drug concentration and hemodynamic effects. |
1990 |
Am. Heart J. |
pmid:2321506
|
Lorenzoni R et al. |
Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study. |
2004 |
Am. Heart J. |
pmid:15215815
|
Buerke M et al. |
Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses. |
1995 |
Am. Heart J. |
pmid:7661062
|
Mehta J et al. |
Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina. |
1984 |
Am. Heart J. |
pmid:6695662
|
De Servi S et al. |
Coronary vasoconstrictor response to cold pressor test in variant angina: lack of relation to intracoronary thromboxane concentrations. |
1987 |
Am. Heart J. |
pmid:3630891
|
Cotter G et al. |
Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? |
2004 |
Am. Heart J. |
pmid:14760328
|
Mehta J and Mehta P |
Prostacyclin and thromboxane A2 production by human cardiac atrial tissues. |
1985 |
Am. Heart J. |
pmid:3880988
|
Friedrich T et al. |
Follow-up of prostaglandin plasma levels after acute myocardial infarction. |
1985 |
Am. Heart J. |
pmid:3880994
|
O'Connor KM et al. |
The effect of thromboxane inhibition on vulnerability to ventricular fibrillation in the acute and chronic feline infarction models. |
1989 |
Am. Heart J. |
pmid:2929400
|
Zhu BQ and Parmley WW |
Modification of experimental and clinical atherosclerosis by dietary fish oil. |
1990 |
Am. Heart J. |
pmid:2105047
|
Neri Serneri GG et al. |
Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. |
1985 |
Am. Heart J. |
pmid:3984828
|
O'Connor KM et al. |
Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion. |
1986 |
Am. Heart J. |
pmid:3953390
|
Roy L et al. |
Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery disease. |
1985 |
Am. Heart J. |
pmid:3158183
|
Austin JC et al. |
Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion. |
1988 |
Am. Heart J. |
pmid:3344655
|
Yamada Y et al. |
Possible mechanism of vascular reocclusion after initially successful thrombolysis with recombinant tissue-type plasminogen activator. |
1991 |
Am. Heart J. |
pmid:1903579
|
Arora RR et al. |
Laser-induced stimulation of thromboxane B2 synthesis in human blood platelets: role of superoxide radicals. |
1993 |
Am. Heart J. |
pmid:8381256
|
FitzGerald GA et al. |
Cigarette smoking and hemostatic function. |
1988 |
Am. Heart J. |
pmid:3276116
|
Jouve R et al. |
Thromboxane B2, 6-keto-PGF1 alpha, PGE2, PGF2 alpha, and PGA1 plasma levels in arteriosclerosis obliterans: relationship to clinical manifestations, risk factors, and arterial pathoanatomy. |
1984 |
Am. Heart J. |
pmid:6581715
|
Rebuzzi AG et al. |
Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis. |
1992 |
Am. Heart J. |
pmid:1539506
|
Takase B et al. |
Effects of bepridil on silent myocardial ischemia and eicosanoid metabolism in chronic stable angina pectoris after healing of myocardial infarction. |
1994 |
Am. J. Cardiol. |
pmid:8198031
|
Catella-Lawson F et al. |
Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease. |
2001 |
Am. J. Cardiol. |
pmid:11472700
|
Faraday N et al. |
Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. |
2006 |
Am. J. Cardiol. |
pmid:16950183
|
McDaniel HG et al. |
Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction. |
1983 |
Am. J. Cardiol. |
pmid:6416046
|
De Caterina R et al. |
Inhibition of platelet function by injectable isosorbide dinitrate. |
1984 |
Am. J. Cardiol. |
pmid:6428211
|
Eldar M et al. |
Bradykinin level in the great cardiac vein during balloon angioplasty of the left anterior descending coronary artery. |
1992 |
Am. J. Cardiol. |
pmid:1466338
|
Hirsh PD et al. |
Effects of provocation on transcardiac thromboxane in patients with coronary artery disease. |
1983 |
Am. J. Cardiol. |
pmid:6829431
|
Shen H et al. |
Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study). |
2009 |
Am. J. Cardiol. |
pmid:19660620
|
Timmermans C et al. |
Ridogrel in the setting of percutaneous transluminal coronary angioplasty. |
1991 |
Am. J. Cardiol. |
pmid:1872272
|